Ledger.Open graph →
SEC Form D · Amendment · filed October 12, 2023

CuraSen Therapeutics, Inc

Offering
$20.8M
Sold
$17.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Carlos, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Ron S. Hunt · San Carlos, CADirectorSimon S. Tate · San Carlos, CADirectorLoretta S. Tse, Ph.D · San Carlos, CADirectorKathleen S. Glaub · San Carlos, CADirectorBenjamin S. Potter · Menlo Park, CAExecPatrick S. Enright · San Carlos, CADirectorAnthony P. Ford · San Carlos, CAExec · DirectorPeter A. Hunter · Boston, MAExecSamuel E. Peck · Dallas, TXDirectorBenjamin Singh · Grand Cayman, Cayman IslandsDirectorJoseph Hurley · Atlanta, GADirectorBradley Rymer · Bonita Springs, FLDirectorThomas Miller · Bonita Springs, FLDirectorUjwala Katkade · Dallas, TXExec · DirectorBrian Goldberg · Bethlehem, PADirectorErin Lifeso · Bethlehem, PAExec · DirectorSteven T. Faraone · Cleveland, OHDirectorKurt D. Watson · Cleveland, OHDirectorMichael A. Murray · Cleveland, OHDirectorRobert Nistico · FORT LAUDERDALE, FLDirectorAndres Tinajero · Toronto, Ontario, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗